IMU

2.08%

4.9¢ imugene limited

Media Thread, page-12620

First 12620 Last

Share
Profile

Follow
rvajna

8,899 Posts.

651

22/03/24

23:35

Post #: 73021909
Share

Originally posted by Taureanbull: ↑

Hawkbar, The company doesn’t need to arrive at its final destination for the share price to move. As I have pointed out several times, the company does want to move onto the NASDAQ. It does have major international investors watching the OASIS trial closely. The company has also employed a corporate strategist.. A lot of money has already been spent preparing for a NASDAQ listing. And we have several trial results for our platforms being released this year.

The stock market is very cable of relating a stock without seeing a big pharma deal. This company has made incredible progress in the last two years. At some stage this progress will be reflected in the share price, Whilst it may seem like it’s sat idle forever this does not predict forward shareprice movement. As with the big effort to push our clinical programs ahead, after we get the results released, the company will use these results as a catalyst to push our ahead our corporate strategy and the share price will respond accordingly.

There is a reason we are seeing this flurry of media activity. Did you also note in the last video of Leslie Chong, mentioned “ a recent presentation to US investors”. Whilst we haven’t seen a video, posted here and do not have any further information, it does hint that she is presenting to them. And it’s unlikely to be Mums and Dads . The US has a quite large and sophisticated BIOTECH focussed investment community. As opposed to Australia that has a very thin sprinkling of mums and dads.

It’s very much my experience that the SP,of a successful Biotexh will rerate rapidly when institutional investors come on board . This hasn’t happened to IMU as yet, in part because dour domestic fund managers don’t touch Biotexh. But US investors have a huge appetite for future disruptive technologies.

And that is exactly what IMU is about to unveil. The results of trials . That’s is why they dumped ALA , because our drugs are so good they don’t need ALA. All of this has been presented in the 4 videos and assorted other social media posts and announcements.

I personally got a lot from Dr Bradley Glovers presentation. And further as I shared with this board, I was lucky enough to have the opportunity to meet him and ask why he joined IMU. He reinforced his reasons again yesterday.

As he is a highly qualified expert on Celular Therapies , I’m very happy to take his word , that we have an amazing portfolio of assets here, And I’m happy to trust that major investors will see this opportunity resulting in a major relating of our share price.A Market Cap of just US$520M is clearly ridiculously low.

Expand

Serial pumping does not get the share price up.

IMU Price at posting: 10.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

IMA

Issues emerging as Australian companies tackle critical minerals challenge

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

There are more pages in this discussion • 3,187 more messages in this thread...

First 12620 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 4.9¢		Change 0.001(2.08%)		Mkt cap ! $364.4M

Open	High	Low	Value	Volume
4.8¢	4.9¢	4.8¢	$179.8K	3.692M

Buyers (Bids)

No.	Vol.	Price($)
62	8124186	4.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.9¢	3070575	9

View Market Depth

No.	Vol.	Price($)
56	7804777	0.048
47	5437350	0.047
38	3197542	0.046
58	3766545	0.045
11	1019564	0.044

Price($)	Vol.	No.
0.049	2050167	7
0.050	5223480	23
0.051	4434080	10
0.052	2536519	9
0.053	1966973	9

Last trade - 16.10pm 11/10/2024 (20 minute delay)

IMU (ASX) Chart

Media Thread, page-12620

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

NRW Holdings inks $109M deal with BHP for works at Jimblebar

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Cauldron Energy reports "excellent" uranium assays in latest drill run

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Issues emerging as Australian companies tackle critical minerals challenge

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Media Thread, page-12620

Top Stories

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

NRW Holdings inks $109M deal with BHP for works at Jimblebar

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Cauldron Energy reports "excellent" uranium assays in latest drill run

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Issues emerging as Australian companies tackle critical minerals challenge

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News